Company / Shareholders' Equity
ABEONA THERAPEUTICS INC. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$159.2M
FY2025
5-year range
$14.8M / $159.2M
FY2021-FY2025
Trend
+973.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity changed +974% YoY in FY2025, a notable deviation from the 9-year average annual change of +395%.
Based on SEC 10-K filings.
$159M in FY2025 with a 5-year CAGR of -2.3%.
Improved from $27M to $159M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +55.5%
- 5-Year CAGR
- -2.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -2.3%, indicating a declining trend.
- In FY2025, shareholders' equity increased 973.9% year-over-year.
- Peak shareholders' equity was recorded in FY2020.
- Lowest shareholders' equity in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -2.42 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $159.2M | +973.9% |
| FY2024 | $14.8M | -44.6% |
| FY2023 | $26.8M | -36.8% |
| FY2022 | $42.4M | -58.7% |
| FY2021 | $102.6M | -42.5% |
| FY2020 | $178.4M | +2732.2% |
| FY2019 | $6.3M | -95.3% |
| FY2018 | $134.0M | -21.2% |
| FY2017 | $170.1M | +151.2% |
| FY2016 | $67.7M | +1306.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026